Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by the negative expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor-2 (HER-2), and it accounts for 15-20% of all breast cancers (1). This evidence concerns the gene ERBB2 and breast cancer.